{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T05:27:39Z","timestamp":1697693259363},"reference-count":5,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2006,9,23]],"date-time":"2006-09-23T00:00:00Z","timestamp":1158969600000},"content-version":"vor","delay-in-days":10492,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archiv der Pharmazie"],"published-print":{"date-parts":[[1978,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Medrogeston besitzt eine metastabile Mod. II, die in dem untersuchten Handelspr\u00e4parat vorliegt. Au\u00dferdem wird noch eine instabile Mod. III beschrieben. Von Phensuximid konnten neben der stabilen noch zwei weitere Formen hergestellt werden. Sie werden durch den Schmp. und die IR\u2010Spektren charakterisiert. Bei Protionamid liegt Enantiotropie zwischen Mod. I und Mod. II vor, das verwendete Handelspr\u00e4parat stellt Mod. II dar. Mod. III und Mod. IV sind relativ instabil.<\/jats:p>","DOI":"10.1002\/ardp.19783110908","type":"journal-article","created":{"date-parts":[[2006,10,16]],"date-time":"2006-10-16T13:49:21Z","timestamp":1161006561000},"page":"757-761","source":"Crossref","is-referenced-by-count":4,"title":["Zur Polymorphie von Arzneistoffen: Medrogeston, Phensuximid und Protionamid"],"prefix":"10.1002","volume":"311","author":[{"given":"Maria","family":"Kuhnert\u2010Brandst\u00e4tter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lothar","family":"B\u00f6sch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,9,23]]},"reference":[{"key":"e_1_2_1_1_2","unstructured":"DissertationL. B\u00f6sch Innsbruck1977."},{"key":"e_1_2_1_2_2","volume-title":"The Merck Index","year":"1976"},{"key":"e_1_2_1_3_2","unstructured":"DissertationG. Eckstein Innsbruck1975."},{"key":"e_1_2_1_4_2","unstructured":"British Pharmaceutical Codex1973."},{"key":"e_1_2_1_5_2","unstructured":"Pharmacop. Japonica Ed. septa1973."}],"container-title":["Archiv der Pharmazie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fardp.19783110908","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ardp.19783110908","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T18:17:11Z","timestamp":1697653031000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ardp.19783110908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1978,1]]},"references-count":5,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1978,1]]}},"alternative-id":["10.1002\/ardp.19783110908"],"URL":"https:\/\/doi.org\/10.1002\/ardp.19783110908","archive":["Portico"],"relation":{},"ISSN":["0365-6233","1521-4184"],"issn-type":[{"value":"0365-6233","type":"print"},{"value":"1521-4184","type":"electronic"}],"subject":[],"published":{"date-parts":[[1978,1]]}}}